Arcutis Biotherapeutics, Inc. ($ARQT)
Filing Information
| Accession Number | 0001628280-26-056898 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 14, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
45,000
Total Value
$449,496.77
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reporting Person's title: EVP, Chief Medical Officer | Common Stock | โ | Aug 11, 2026 | Exercise/Conversion | 8,300 | $3.64 | $30,212.00 | 127,589 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Medical Officer | Common Stock | โ | Aug 11, 2026 | Sale | 8,300 | $26.52 | $220,129.28 | 119,289 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Medical Officer | Common Stock | โ | Aug 12, 2026 | Exercise/Conversion | 6,700 | $3.64 | $24,388.00 | 125,989 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Medical Officer | Common Stock | โ | Aug 12, 2026 | Sale | 6,700 | $26.08 | $174,767.49 | 119,289 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Medical Officer | Stock Option (right to buy) | Derivative | Aug 11, 2026 | Exercise/Conversion | 8,300 | $0.00 | $0.00 | 135,450 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Medical Officer | Stock Option (right to buy) | Derivative | Aug 12, 2026 | Exercise/Conversion | 6,700 | $0.00 | $0.00 | 128,750 | Direct | โ | View Details |